Skip to main content
SpringerLink
Log in

Controversial Indications for Breast Conserving Therapy and Radiation

  • Chapter
  • First Online:
Book cover Breast Surgical Techniques and Interdisciplinary Management

  • 2514 Accesses

Abstract

Breast conserving surgery followed by radiation therapy is the accepted standard of care for a majority of women with early-stage invasive breast cancer and ductal carcinoma in situ. While there are relatively few contraindications to breast conserving surgery, there are several areas of controversy and special circumstances in the selection of patients for breast conserving therapy followed by radiation therapy to the whole breast that warrant specific discussion. Discussed in this chapter is breast conserving surgery in the setting of BRCA1/2 mutations, in the setting of collagen vascular disease, and in women who received prior radiation therapy to the chest for Hodgkin’s disease or other malignancies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Easton DF. How many more breast cancer predisposition genes are there? Breast Cancer Res. 1999;1:14–7.

    Article  PubMed  CAS  Google Scholar 

  2. Easton DF, Steele L, Fields P, et al. Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am J Hum Genet. 1997;61:120–8.

    Article  PubMed  CAS  Google Scholar 

  3. Ford D, Easton DF, Peto J. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet. 1995;57:1457–62.

    PubMed  CAS  Google Scholar 

  4. Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 1998;62:676–89.

    Article  PubMed  CAS  Google Scholar 

  5. Robson ME, Boyd J, Borgen PI, et al. Hereditary breast cancer. Curr Probl Surg. 2001;38:387–480.

    Article  PubMed  CAS  Google Scholar 

  6. Anon. Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium. J Natl Cancer Inst. 1999;91:1310–6.

    Google Scholar 

  7. Ansquer Y, Gautier C, Fourquet A, et al. Survival in early-onset BRCA1 breast-cancer patients. Institut Curie Breast Cancer Group. Lancet. 1998;352:541.

    Article  PubMed  CAS  Google Scholar 

  8. Robson ME, Chappuis PO, Satagopan J, et al. A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment. Breast Cancer Res. 2004;6:R8–17.

    Article  PubMed  CAS  Google Scholar 

  9. Seynaeve C, Verhoog LC, Van De Bosch LM, et al. Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy. Eur J Cancer. 2004;40:201050–8.

    Article  Google Scholar 

  10. Anon. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group. Br J Cancer. 2000;83:1301–8.

    Google Scholar 

  11. Alpert TE, Haffty BG. Conservative management of breast cancer in BRCA1/2 mutation carriers. Clin Breast Cancer. 2004;5:37–42.

    Article  PubMed  Google Scholar 

  12. Haffty BG. Molecular and genetic markers in the local-regional management of breast cancer. Semin Radiat Oncol. 2002;12:329–40.

    Article  PubMed  Google Scholar 

  13. Robson M, Svahn T, McCormick B, et al. Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: a clinic-based series. Cancer. 2005;103:44–51.

    Article  PubMed  Google Scholar 

  14. Haffty BG, Harrold E, Khan AJ, et al. Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status. Lancet. 2002;359:1471–7.

    Article  PubMed  Google Scholar 

  15. Pierce LJ, Levin AM, Rebbeck TR, et al. Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer. J Clin Oncol. 2006;24:2437–43.

    Article  PubMed  Google Scholar 

  16. Robson M, Levin D, Federici M, et al. Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations. J Natl Cancer Inst. 1999;91:220102–7.

    Article  Google Scholar 

  17. Steinmann D, Bremer M, Rades D, et al. Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer. Br J Cancer. 2001;85:850–8.

    Article  PubMed  CAS  Google Scholar 

  18. Kirova YM, Stoppa-Lyonnet D, Savignoni A, et al. Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy. Eur J Cancer. 2005;41:2304–2010.

    Article  PubMed  Google Scholar 

  19. Pierce LJ, Strawderman M, Narod SA, et al. Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations. J Clin Oncol. 2000;18:3360–9.

    PubMed  CAS  Google Scholar 

  20. Narod SA, Brunet JS, Ghadirian P, et al. Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group. Lancet. 2000;356:1876–81.

    Article  PubMed  CAS  Google Scholar 

  21. Rebbeck TR. Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers. J Clin Oncol. 2000;18:100S–3.

    PubMed  CAS  Google Scholar 

  22. Wo J, Taghian A. Radiotherapy in setting of collagen vascular disease. Int J Radiat Oncol Biol Phys. 2007;69:1347–53.

    Article  PubMed  Google Scholar 

  23. Lin A, Abu-Isa E, Griffith KA, et al. Toxicity of radiotherapy in patients with collagen vascular disease. Cancer. 2008;20103:648–53.

    Article  Google Scholar 

  24. Fleck R, McNeese MD, Ellerbroek NA, et al. Consequences of breast irradiation in patients with pre-existing collagen vascular diseases. Int J Radiat Oncol Biol Phys. 1989;17:829–33.

    Article  PubMed  CAS  Google Scholar 

  25. Morris MM, Powell SN. Irradiation in the setting of collagen vascular disease: acute and late complications. J Clin Oncol. 1997;15:2728–35.

    PubMed  CAS  Google Scholar 

  26. De Naeyer B, De Meerleer G, Braems S, et al. Collagen vascular diseases and radiation therapy: a critical review. Int J Radiat Oncol Biol Phys. 1999;44:975–80.

    Article  PubMed  Google Scholar 

  27. Phan C, Mindrum M, Silverman C, et al. Matched-control retrospective study of the acute and late complications in patients with collagen vascular diseases treated with radiation therapy. Cancer J. 2003;9:461–6.

    Article  PubMed  Google Scholar 

  28. Rakfal SM, Deutsch M. Radiotherapy for malignancies associated with lupus: case reports of acute and late reactions. Am J Clin Oncol. 1998;21:54–7.

    Article  PubMed  CAS  Google Scholar 

  29. Robertson JM, Clarke DH, Pevzner MM, et al. Breast conservation therapy. Severe breast fibrosis after radiation therapy in patients with collagen vascular disease. Cancer. 1991;68: 502–8.

    Article  PubMed  CAS  Google Scholar 

  30. Ross JG, Hussey DH, Mayr NA, et al. Acute and late reactions to radiation therapy in patients with collagen vascular diseases. Cancer. 1993;71:3744–52.

    Article  PubMed  CAS  Google Scholar 

  31. Chen AM, Obedian E, Haffty BG. Breast-conserving therapy in the setting of collagen vascular disease. Cancer J. 2001;7:480–91.

    PubMed  CAS  Google Scholar 

  32. Travis LB, Hill D, Dores GM, et al. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J Natl Cancer Inst. 2005;97:1428–37.

    Article  PubMed  Google Scholar 

  33. Cutuli B, Borel C, Dhermain F, et al. Breast cancer occurred after treatment for Hodgkin’s disease: analysis of 133 cases. Radiother Oncol. 2001;59:247–55.

    Article  PubMed  CAS  Google Scholar 

  34. Wolden SL, Hancock SL, Carlson RW, et al. Management of breast cancer after Hodgkin’s disease. J Clin Oncol. 2000;18:765–72.

    PubMed  CAS  Google Scholar 

  35. Intra M, Leonardi MC, Gatti G, et al. Intraoperative radiotherapy during breast conserving surgery in patients previously treated with radiotherapy for Hodgkin’s disease. Tumori. 2004;90:13–6.

    PubMed  Google Scholar 

  36. Deutsch M, Gerszten K, Bloomer WD, et al. Lumpectomy and breast irradiation for breast cancer arising after previous radiotherapy for Hodgkin’s disease or lymphoma. Am J Clin Oncol. 2001;24:33–4.

    Article  PubMed  CAS  Google Scholar 

  37. Alpert TE, Kuerer HM, Arthur DW, et al. Ipsilateral breast tumor recurrence after breast conservation therapy: outcomes of salvage mastectomy vs. salvage breast-conserving surgery and prognostic factors for salvage breast preservation. Int J Radiat Oncol Biol Phys. 2005;63:845–51.

    Article  PubMed  Google Scholar 

  38. Arthur DW, Vicini FA. Accelerated partial breast irradiation as a part of breast conservation therapy. J Clin Oncol. 2005;23:1726–35.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry, New Brunswick, NJ, USA

    Bruce G. Haffty

Authors
  1. Bruce G. Haffty
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bruce G. Haffty .

Editor information

Editors and Affiliations

  1. Middle Ave. 1285, Menlo Park, 94025, California, USA

    Frederick Dirbas

  2. Iowa City, USA

    Carol Scott-Conner

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer New York

About this chapter

Cite this chapter

Haffty, B.G. (2010). Controversial Indications for Breast Conserving Therapy and Radiation. In: Dirbas, F., Scott-Conner, C. (eds) Breast Surgical Techniques and Interdisciplinary Management. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-6076-4_75

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-6076-4_75

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-6075-7

  • Online ISBN: 978-1-4419-6076-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation